SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Hessman Eva 1961)
 

Sökning: WFRF:(Hessman Eva 1961) > Inflammatory cardio...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004114naa a2200385 4500
001oai:gup.ub.gu.se/289765
003SwePub
008240910s2020 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/2897652 URI
024a https://doi.org/10.1007/s10741-020-09919-x2 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Bobbio, Emanueleu Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine4 aut0 (Swepub:gu)xbobem
2451 0a Inflammatory cardiomyopathies: short- and long-term outcomes after heart transplantation-a protocol for a systematic review and meta-analysis.
264 c 2020-01-14
264 1b Springer Science and Business Media LLC,c 2020
520 a Heart transplantation (HTx) for patients with "giant cell myocarditis" (GCM) or "cardiac sarcoidosis" (CS) is still controversial. However, no single center has accumulated enough experience to investigate post-HTx outcome. The primary aim of this systematic review is to identify, appraise, and synthesize existing literature investigating whether patients who have undergone HTx because of GCM or CS have worse outcomes as compared with patients transplanted because of other etiologies. A systematic and comprehensive search will be performed using PubMed, Scopus, Web of Science, EMBASE, and Google Scholar, for studies published up to December 2019. Observational and interventional population-based studies will be eligible for inclusion. The quality of observational studies will be assessed using the Newcastle-Ottawa scale, while the interventional studies will be assessed using the Cochrane Effective Practice Organization of Care tool. The collected evidence will be narratively synthesized; in addition, we will perform a meta-analysis to pool estimates from studies considered to be homogenous. Reporting of the systematic review and meta-analysis will be in accordance with the Meta-analysis of Observational Studies in Epidemiology Preferred Reporting Items for Systematic reviews and Meta-Analysis guidelines. To our knowledge, this will be the first synthesis of outcomes, including survival, acute cellular rejection, and disease recurrence, in patients with either GCM or CS treated with HTx. Reviewing the suitability of HTx in this population and highlighting areas for further research will benefit both patients and healthcare providers. Trial registration: CRD42019140574.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskap0 (SwePub)3032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciences0 (SwePub)3032 hsv//eng
700a Lingbrant, Marieu Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine4 aut
700a Nwaru, Bright I,d 1978u Gothenburg University,Göteborgs universitet,Krefting Research Centre4 aut0 (Swepub:gu)xnwabr
700a Hessman, Eva,d 1961u Gothenburg University,Göteborgs universitet,Göteborgs universitetsbibliotek, Biomedicinska biblioteken,Gothenburg University Library, Biomedical Libraries4 aut0 (Swepub:gu)xhesev
700a Lehtonen, Jukka4 aut
700a Karason, Kristjan,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine4 aut0 (Swepub:gu)xkarkr
700a Bollano, Entela,d 1970u Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine4 aut0 (Swepub:gu)xbolen
710a Göteborgs universitetb Institutionen för medicin4 org
773t Heart failure reviewsd : Springer Science and Business Media LLCg 25:3, s. 481-485q 25:3<481-485x 1573-7322x 1382-4147
856u https://link.springer.com/content/pdf/10.1007/s10741-020-09919-x.pdf
8564 8u https://gup.ub.gu.se/publication/289765
8564 8u https://doi.org/10.1007/s10741-020-09919-x

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy